Homocysteine and essential hypertension

Ramón Rodrigo1, Walter Passalacqua, Julia Araya

  • 1Instituto de Ciencias Biomédicas, Programa de Farmacología Molecular y Clínica, Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Insights

High homocysteine levels may contribute to essential hypertension by impairing blood vessel function. Supplementing with B vitamins and folic acid might help manage blood pressure, but more research is needed.

Area of Science:

  • Cardiovascular Research
  • Hypertension Pathogenesis
  • Vascular Biology

Background:

  • Essential hypertension mechanisms remain unclear, potentially involving vascular endothelial and smooth muscle cell dysfunction.
  • Endothelial dysfunction can disrupt normal endothelium-dependent vasomotor regulation.
  • Homocysteine is an emerging risk factor for cardiovascular disease.

Purpose of the Study:

  • To review clinical and experimental data on homocysteine's role in essential hypertension pathogenesis.
  • To explore the mechanisms by which homocysteine may influence blood pressure regulation.

Main Methods:

  • Review of existing clinical and experimental data.
  • Analysis of homocysteine's effects on vascular function, nitric oxide bioavailability, oxidative stress, and vascular wall properties.

Main Results:

  • Elevated homocysteine diminishes nitric oxide-mediated vasodilation.
  • High homocysteine levels increase oxidative stress and vascular smooth muscle cell proliferation.
  • Homocysteine alters vascular wall elasticity, contributing to elevated blood pressure and endothelial oxidant injury.

Conclusions:

  • Homocysteine is implicated in the pathogenesis of essential hypertension through vascular dysfunction.
  • Vitamin B12, B6, and folic acid supplementation may offer an adjunctive therapy for hypertension.
  • Further randomized controlled trials are required to confirm the efficacy and safety of vitamin therapy for hypertension.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...